Stockreport

Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]

Sensei Biotherapeutics, Inc.  (SNSE) 
PDF - Cash runway extended into the second quarter of 2026 - BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biote [Read more]